Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NOS inhibitors with selectivity for the neuronal isoform synthesized at Schering AG

Jan. 20, 1999

More on AMPA antagonists under study at Pfizer

Jan. 20, 1999

Melatonergic agents in development at Bristol-Myers Squibb

Jan. 20, 1999

AMPA antagonists and their use described by Pfizer

Jan. 19, 1999

Novartis initiates phase III trial of schizophrenia treatment

Jan. 18, 1999

Cortex licenses Ampakine rights to Organon

Jan. 18, 1999

Takeda develops compounds that induce and/or enhance cell differentiation

Jan. 18, 1999

Selective dopamine D3 receptor modulators synthesized at SB

Jan. 18, 1999

SmithKline Beecham describes novel compounds for depression and other CNS disorders

Jan. 18, 1999

CLASS study evaluates clomethiazole in acute stroke patients

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...